Sankar Shyam
- SEC CIK
- 0001824159
In the past year, 5 open-market sale filings worth $102.0M and no purchases.
Current role at each company
- PLTR Palantir Technologies Inc.See Remarksas of Aug 12, 2026
- DNA Ginkgo Bioworks Holdings, Inc.Directoras of Jun 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $102.0M
- 5 filings
- Net
- −$102.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sankar Shyam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PLTR Palantir Technologies Inc.
See Remarks36 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2021 (view filing) | Jul 19 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −172.5K | $21.31 | −$3.68M | −6.3%2.56M after | 2 lots |
| Aug 24, 2021 (view filing) | Aug 20-24 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −585.3K | $24.52 | −$14.4M | −19.9%2.35M after | 3 lots |
| Nov 24, 2021 (view filing) | Nov 22-24 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −585.3K | $20.86 | −$12.2M | −20.8%2.23M after | 4 lots |
| Feb 23, 2022 (view filing) | Feb 22-23 | 1 day | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −266.9K | $10.70 | −$2.85M | −11.1%2.13M after | 2 lots |
| May 24, 2022 (view filing) | May 20-24 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −274.4K | $7.99 | −$2.19M | −11.9%2.03M after | 3 lots |
| Jul 26, 2022 (view filing) | Jul 22 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −125.0K | $9.95 | −$1.24M | −6.1%1.92M after | |
| Aug 24, 2022 (view filing) | Aug 22-24 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −274.8K | $8.15 | −$2.24M | −11.8%2.06M after | 3 lots |
| Aug 29, 2022 (view filing) | Aug 25 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −50.0K | $8.28 | −$414.0K | −2.4%2.01M after | |
| Nov 23, 2022 (view filing) | Nov 21-23 | 2 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −278.0K | $7.19 | −$2.00M | −12.7%1.91M after | 3 lots |
| Nov 29, 2022 (view filing) | Nov 25 | 4 days | Sankar ShyamSee Remarks | SSaleClass A Common Stock | −50.0K | $7.24 | −$362.0K | −2.6%1.86M after |
DNA Ginkgo Bioworks Holdings, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2023 (view filing) | May 18 | 4 days | Sankar ShyamDirector | PPurchaseClass A Common Stock | +400.0K | $1.28 | +$512.0K | +30.0%1.73M after | |
| May 16, 2024 (view filing) | May 15 | 1 day | Sankar ShyamDirector | PPurchaseClass A Common Stock | +625.0K | $0.82 | +$512.5K | +36.1%2.36M after |